Health Care & Life Sciences » Pharmaceuticals | Ouro Fino Saude Animal Participacoes S/A

Ouro Fino Saude Animal Participacoes S/A Ord | Income Statement

Fiscal year is January-December. All values BRL Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
384,021.00
327,360.00
534,045.00
456,587.00
505,281.00
589,215
Cost of Goods Sold (COGS) incl. D&A
149,098.00
137,658.00
244,649.00
234,968.00
246,415.00
265,085
Gross Income
234,923.00
189,702.00
289,396.00
221,619.00
258,866.00
324,130
SG&A Expense
168,280.00
120,683.00
193,535.00
206,529.00
186,813.00
216,787
EBIT
65,770.00
68,387.00
96,362.00
14,597.00
65,729.00
107,343
Unusual Expense
69.00
717.00
11,098.00
31,771.00
6,669.00
4,562
Non Operating Income/Expense
753.00
9,093.00
13,853.00
12,035.00
1,024.00
14,143
Interest Expense
12,473.00
7,826.00
10,695.00
12,280.00
18,185.00
20,959
Pretax Income
57,992.00
54,105.00
87,267.00
13,350.00
49,558.00
82,824
Income Tax
4,103.00
15,227.00
18,060.00
7,999.00
11,657.00
13,957
Consolidated Net Income
53,889.00
38,878.00
69,207.00
5,351.00
37,901.00
68,867
Net Income
53,889.00
38,408.00
69,192.00
5,206.00
38,108.00
68,867
Net Income After Extraordinaries
65,773.00
39,096.00
69,192.00
5,206.00
38,108.00
68,867
Net Income Available to Common
42,005.00
37,720.00
69,192.00
5,206.00
38,108.00
68,867
EPS (Basic)
3.12
1.06
1.28
0.10
0.71
1.28
Basic Shares Outstanding
13,461.50
35,604.00
53,942.00
53,946.00
53,949.00
-
EPS (Diluted)
3.12
1.06
1.28
0.10
0.71
-
Diluted Shares Outstanding
13,461.50
35,604.00
54,012.00
53,983.00
53,949.00
-
EBITDA
78,255.00
79,700.00
116,494.00
36,524.00
90,588.00
132,875
Other Operating Expense
873.00
632.00
501.00
493.00
6,324.00
-
Non-Operating Interest Income
4,011.00
1,920.00
4,355.00
4,069.00
7,659.00
6,021
Minority Interest Expense
-
470.00
15.00
145.00
207.00
-

About Ouro Fino Saude Animal Participacoes

View Profile
Address
Rodovia Anhanguera, SP 330, Km 298
Cravinhos Sao Paulo 14140
Brazil
Employees -
Website http://www.ourofino.com
Updated 07/08/2019
Ouro Fino Saúde Animal Participações SA engages in the manufacture and selling of medicines, vaccines, and veterinary products for farm and companion animals, such as cattle, horses, and pigs. It operates through the following segments: Production Animals, Companion Animals, and International Operations. The Production Animals segment produces and sells veterinary drugs, such as anti-inflammatory and anticoccidial drugs; antibiotics; anti-mastitis drugs; ectoparasiticides; endectocides; endoparasiticides; hemoparasiticides; inoculants; therapeutic products; and products for animal breeding vaccines.